Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01348529
Other study ID # OCDP1
Secondary ID
Status Completed
Phase N/A
First received November 8, 2010
Last updated March 19, 2018
Start date September 2010
Est. completion date March 2011

Study information

Verified date September 2010
Source Karolinska Institutet
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main aim of this study is to test whether cognitive behavior therapy could be effective in treating obsessive compulsive disorder. Here, the investigators test the in group effects of a 15 week long treatment delivered via the Internet for residents in Stockholm County.


Recruitment information / eligibility

Status Completed
Enrollment 23
Est. completion date March 2011
Est. primary completion date March 2011
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Diagnosed with Obsessive compulsive disorder according to the DSM criteria

- Be at least 18 years old

- YBOCS >7

Exclusion Criteria:

- other primary diagnosis

- substance abuse,

- psychosis,

- bipolar disorder,

- suicidal ideation,

- adjusted pharmacological treatment the last two months

- current psychological treatment for OCD,

- been treated with CBT the last two years,

- serious somatic disease,

- Y---BOCS>31

- hoarding as primary OCD subtype

Study Design


Intervention

Behavioral:
Internet CBT
Internet-delivered cognitive behavioral therapy with therapist support.

Locations

Country Name City State
Sweden Internetpsykatrienheten, M46, Psykiatri sydväst Stockholm

Sponsors (1)

Lead Sponsor Collaborator
Karolinska Institutet

Country where clinical trial is conducted

Sweden, 

References & Publications (1)

Andersson E, Ljótsson B, Hedman E, Kaldo V, Paxling B, Andersson G, Lindefors N, Rück C. Internet-based cognitive behavior therapy for obsessive compulsive disorder: a pilot study. BMC Psychiatry. 2011 Aug 3;11:125. doi: 10.1186/1471-244X-11-125. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change from Baseline of obsessions and compulsions after 15 weeks and 6 months after treatment. Yale Brown Obsessive Compulsive Scale (Y-BOCS) Psychiatrist visit at baseline, after 15 weeks of treatment and 6 months after treatment.
Secondary Change from Baseline of cost data after 15 weeks and 6 months after treatment. "Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry". In this questionnaire, patients register their monthly health care consumption (e.g. GP visits) as well as time spent in informal health enhancing activities (e.g. self-help groups and informal care from friends). In addition, work loss and work cutback both at work and in the domestic realm is measured. Self-ratings at baseline, after 15 weeks of treatment and 6 months after treatment.
Secondary Change from Baseline of depressive symptoms after 15 weeks and 6 months after treatment. The Montgomery Åsberg Depression Rating Scale Sel-ratings at baseline, after 15 weeks of treatment and 6 months after treatment.
Secondary Change from Baseline of obsessions and compulsions after 15 weeks and 6 months after treatment. Obsessions and Compulsions Inventory Revised Self-ratings at baseline, after 15 weeks of treatment and at 6 months after treatment.
Secondary Change from Baseline of quality of life after 15 weeks and 6 months after treatment EuroQol Self-ratings at baseline, after 15 weeks of treatment and at 6 months after treatment.
Secondary Change from Baseline of quality of life after 15 weeks and 6 months after treatment Quality of life inventory Self-ratings at baseline, after 15 weeks of treatment and at 6 months after treatment.
See also
  Status Clinical Trial Phase
Recruiting NCT04631042 - Developing Brain, Impulsivity and Compulsivity
Completed NCT02855580 - Integrating Pharmacogenomic Testing Into a Child Psychiatry Clinic
Completed NCT02229903 - An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCD N/A
Completed NCT02202915 - CBT for Pediatric OCD: Community Training Pilot N/A
Completed NCT01794156 - Evaluation of a Cognitive Therapy (Inference-based-therapy) for the Treatment of Obsessional Compulsive Disorder N/A
Completed NCT02089984 - Web Based Therapist Training on Cognitive Behavior Therapy for Anxiety Disorders N/A
Recruiting NCT00965211 - Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Safety and Feasibility Study for the Treatment of Tourette Syndrome N/A
Completed NCT01172873 - D-Cycloserine Augmentation to CBT With Exposure and Response Prevention in Adults and Adolescents With OCD N/A
Completed NCT00723060 - Comparison of Effects Between Conventional Dose and High Dose Escitalopram on Clinical Improvement in Patients With Obsessive-compulsive Disorder Phase 4
Not yet recruiting NCT00743834 - Cost-Effectiveness of Adding Web-Based Cognitive-Behavioral Therapy (CBT) to Luvox CR for Obsessive Compulsive Disorder (OCD) Phase 4
Completed NCT02421315 - Overlapping Neural Circuits in Pediatric OCD N/A
Completed NCT02194075 - Methylphenidate Hydrochloride Controlled-Release Tablets Augmentation Strategy for Patients With Obsessive Compulsive Disorder Phase 4
Completed NCT01981317 - Stepped Care Cognitive Behavioral Therapy for Pediatric Obsessive Compulsive Disorder N/A
Completed NCT01686087 - Attaining and Maintaining Wellness in Obsessive-compulsive Disorder N/A
Completed NCT01331876 - Modification of Cerebral Activity of Obsessive Compulsive Disorder (OCD) Patients During Cognitive and Behavioral Therapy N/A
Terminated NCT00997087 - A Randomized, Double-Blind, Placebo-Controlled Trial of Flumazenil for the Treatment of Obsessive Compulsive Disorder Phase 2
Completed NCT00533806 - Comparing the Effectiveness of Two Family-based Therapies in Treating Young Children With Obsessive-Compulsive Disorder Phase 3
Completed NCT00517244 - Evaluating Parenting Styles and Child Temperament Associated With Child Anxiety Disorders N/A
Completed NCT00169377 - Subthalamic Nucleus (STN) Stimulation and Obsessive-Compulsive Disorder (OCD) Phase 1/Phase 2
Completed NCT00116532 - Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD) Phase 4

External Links